/Investor DB

MC Healthcare Ventures — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Alloy Therapeutics, Inc.82vs.cominApr 2026SEC filingmedium confidence

A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies.

BiotechDeep TechWaltham, US

Errik B. Anderson(Executive Officer, Director)inPiotr Bobrowicz(Executive Officer, Director)inJay Rosanelli(Executive Officer)in

BoardAnthony Sun(Director)Ulrik Nielsen(Director)in

Board seatAlaa Halawa· per SEC Form D · $40M raise · filed Apr 2026

Co-investors82VS8VCAlumni VenturesGermin8 VenturesJIC Venture Growth InvestmentsPresight Capital+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ollin Biosciences, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.